185 related articles for article (PubMed ID: 28403564)
41. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
[TBL] [Abstract][Full Text] [Related]
42. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.
Hawkins DS; Arndt CA
Cancer; 2003 Dec; 98(11):2447-56. PubMed ID: 14635080
[TBL] [Abstract][Full Text] [Related]
43. Osteogenic progenitor cell potency after high-dose chemotherapy (COSS-96).
Jäger M; Schultheis A; Westhoff B; Krauspe R
Anticancer Res; 2005; 25(2A):947-54. PubMed ID: 15868932
[TBL] [Abstract][Full Text] [Related]
44. [Goal and results of the COSS study].
Flege S; Bielack S
Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):282-8. PubMed ID: 15503258
[TBL] [Abstract][Full Text] [Related]
45. Total Neoadjuvant vs. Standard Perioperative Cisplatin/ Doxorubicin Chemotherapy in Patients with Extremities Osteosarcoma: A Multi-Center Cohort Study.
Foroughi A; Arefpour AM; Nikoofar A; Sanei M; Mahdavi SH; Javadinia SA
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2369-2374. PubMed ID: 37505768
[TBL] [Abstract][Full Text] [Related]
46. [Neoadjuvant chemotherapy of osteosarcoma. Preliminary results of the cooperative COSS-86 osteosarcoma study].
Bieling P; Bielack S; Delling G; Jürgens H; Kotz R; Dose C; Astheimer H; Exner G; Gadner H; Graf N
Klin Padiatr; 1991; 203(4):220-30. PubMed ID: 1942929
[TBL] [Abstract][Full Text] [Related]
47. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.
Provisor AJ; Ettinger LJ; Nachman JB; Krailo MD; Makley JT; Yunis EJ; Huvos AG; Betcher DL; Baum ES; Kisker CT; Miser JS
J Clin Oncol; 1997 Jan; 15(1):76-84. PubMed ID: 8996127
[TBL] [Abstract][Full Text] [Related]
48. The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma.
Araki Y; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Higuchi T; Abe K; Taniguchi Y; Yonezawa H; Morinaga S; Asano Y; Ikeda H; Nojima T; Tsuchiya H
Sci Rep; 2021 Jan; 11(1):1989. PubMed ID: 33479294
[TBL] [Abstract][Full Text] [Related]
49. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
[TBL] [Abstract][Full Text] [Related]
50. Small cell osteosarcoma successfully treated by high-dose ifosfamide and methotrexate, combined with carboplatin and pirarubicin.
Futani H; Fukunaga S; Tsukamoto Y; Terada N; Ono J; Okamoto N; Otsuka Y; Tanizawa T; Tomatsuri M; Yoshiya S
Anticancer Res; 2012 Mar; 32(3):965-71. PubMed ID: 22399618
[TBL] [Abstract][Full Text] [Related]
51. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
Goorin AM; Schwartzentruber DJ; Devidas M; Gebhardt MC; Ayala AG; Harris MB; Helman LJ; Grier HE; Link MP;
J Clin Oncol; 2003 Apr; 21(8):1574-80. PubMed ID: 12697883
[TBL] [Abstract][Full Text] [Related]
52. P16 protein expression as a useful predictive biomarker for neoadjuvant chemotherapy response in patients with high-grade osteosarcoma: A systematic meta-analysis under guideline of PRISMA.
Tang Y; Yang C; Guo Z; Fu Y; Yu X; Liu B; Zhou H; Wang J; Li W; Pang Q
Medicine (Baltimore); 2017 May; 96(19):e6714. PubMed ID: 28489748
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of ifosfamide-based chemotherapy for osteosarcoma: a meta-analysis.
Fan XL; Cai GP; Zhu LL; Ding GM
Drug Des Devel Ther; 2015; 9():5925-32. PubMed ID: 26604690
[TBL] [Abstract][Full Text] [Related]
54. An expression signature classifies chemotherapy-resistant pediatric osteosarcoma.
Mintz MB; Sowers R; Brown KM; Hilmer SC; Mazza B; Huvos AG; Meyers PA; Lafleur B; McDonough WS; Henry MM; Ramsey KE; Antonescu CR; Chen W; Healey JH; Daluski A; Berens ME; Macdonald TJ; Gorlick R; Stephan DA
Cancer Res; 2005 Mar; 65(5):1748-54. PubMed ID: 15753370
[TBL] [Abstract][Full Text] [Related]
55. Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J.
Iwamoto Y; Tanaka K; Isu K; Kawai A; Tatezaki S; Ishii T; Kushida K; Beppu Y; Usui M; Tateishi A; Furuse K; Minamizaki T; Kawaguchi N; Yamawaki S
J Orthop Sci; 2009 Jul; 14(4):397-404. PubMed ID: 19662473
[TBL] [Abstract][Full Text] [Related]
56. Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma.
Kim MS; Lee SY; Lee TR; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
Ann Oncol; 2009 May; 20(5):955-60. PubMed ID: 19153123
[TBL] [Abstract][Full Text] [Related]
57. Extraskeletal osteosarcoma of the breast in an adolescent girl.
Zils K; Ebner F; Ott M; Müller J; Baumhoer D; Greulich M; Rehnitz D; Rempen A; Schaetzle S; Wilhelm M; Bielack S
J Pediatr Hematol Oncol; 2012 Aug; 34(6):e261-3. PubMed ID: 22246152
[TBL] [Abstract][Full Text] [Related]
58. Age and Tumor Location Predict Survival in Nonmetastatic Osteosarcoma in Upper Egypt.
Morsy AM; Ahmed BM; Rezk KM; Ramadan IK; Aboelgheit AM; Eltyb HA; Abd Elbadee OM; El-Naggar MS
J Pediatr Hematol Oncol; 2020 Mar; 42(2):e66-e78. PubMed ID: 31107367
[TBL] [Abstract][Full Text] [Related]
59. Clinical efficacy of preoperative chemotherapy with or without ifosfamide in patients with osteosarcoma of the extremity: meta-analysis of randomized controlled trials.
Su W; Lai Z; Wu F; Lin Y; Mo Y; Yang Z; Wu J
Med Oncol; 2015 Feb; 32(2):481. PubMed ID: 25575440
[TBL] [Abstract][Full Text] [Related]
60. Postoperative nomogram to predict the probability of metastasis in Enneking stage IIB extremity osteosarcoma.
Kim SH; Shin KH; Kim HY; Cho YJ; Noh JK; Suh JS; Yang WI
BMC Cancer; 2014 Sep; 14():666. PubMed ID: 25216622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]